Distinct Functions of Evolutionary Conserved MSF1 and Late Embryogenesis Abundant (LEA)-like Domains in Mitochondria

PRELID1, the only late embryogenesis abundant (LEA) domain-containing protein in humans, exerts cytoprotective effects through its LEA domain within the mitochondria. Although PRELID1 homologs in vertebrates contain the LEA domain, homologs in lower eukaryotes are thought to lack this domain. In this study, we identify a novel LEA-like domain in a yeast PRELID1 homolog, Ups2p, which contains sequence conservation with the LEA domain of human PRELID1. PRELID1 homologs, including Ups2p, are known to contain the PRELI/MSF1 domain. Our study reveals that the MSF1 domain of Ups2p maintains proper mitochondrial electron transport chain function, respiratory competency, and mitochondrial phosphatidylethanolamine metabolism. The Ups2p MSF1 domain mediates cardiolipin depletion in the absence of Ups1p. However, the Ups2p LEA-like domain is responsible for cardiolipin depletion resulting from UPS2 overexpression. The regulation of phosphatidylethanolamine levels by the MSF1 domain is antagonized by the Ups2p LEA-like domain. We demonstrate that the yeast LEA-like domain protects cells from oxidative stress and can be functionally replaced by the human LEA domain. Together our studies suggest distinct roles of MSF1 and LEA-like domains in mitochondrial function and resistance to oxidative stress. Background: PRELID1 homologs are highly conserved mitochondrial proteins that are poorly characterized. Results: PRELID1 homologs in yeast (UPS1–3) are essential for maintaining multiple mitochondrial processes. Conclusion: Ups2p exerts pleotropic effects on mitochondrial processes through distinct roles of the MSF1 and a newly identified LEA-like domain. Significance: Ups2p is the first cytoprotective LEA-like domain-containing protein identified in yeast.